10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $45,413,824 | -64.2% | 2,334,901 | -31.0% | 0.13% | -62.5% |
| Q1 2024 | $126,969,282 | -36.8% | 3,383,141 | -5.8% | 0.36% | -41.9% |
| Q4 2023 | $200,904,514 | +22.2% | 3,590,145 | -9.9% | 0.61% | +9.1% |
| Q3 2023 | $164,400,637 | -28.5% | 3,985,470 | -3.3% | 0.56% | -21.6% |
| Q2 2023 | $230,075,821 | +10.3% | 4,120,269 | +10.2% | 0.71% | +3.9% |
| Q1 2023 | $208,530,077 | +178352.0% | 3,737,768 | +16.6% | 0.69% | +55.8% |
| Q4 2022 | $116,855 | -99.9% | 3,206,783 | -5.4% | 0.44% | +21.8% |
| Q3 2022 | $96,581,000 | -39.5% | 3,391,177 | -3.8% | 0.36% | -34.4% |
| Q2 2022 | $159,591,000 | -34.5% | 3,526,878 | +10.2% | 0.55% | -1.4% |
| Q1 2022 | $243,530,000 | -1.7% | 3,201,394 | +92.4% | 0.56% | +21.7% |
| Q4 2021 | $247,865,000 | – | 1,663,967 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |